Filing Details
CUMBERLAND PHARMACEUTICALS INC (NASDAQ:CPIX) filed a Form 8-K with the Securities and Exchange Commission on July 13, 2026, disclosing a material event.
8k filedNASDAQ:CPIX
CUMBERLAND PHARMACEUTICALS INC (CPIX) Reports Material Event to SEC
Filing Details CUMBERLAND PHARMACEUTICALS INC (NASDAQ:CPIX) filed a Form 8-K with the Securities and Exchange Commission on July 13, 2026, disclosing a material event. Market…
Market Context
CUMBERLAND PHARMACEUTICALS INC's stock currently trades at $6.54 with a market capitalization of $37.0M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for CUMBERLAND PHARMACEUTICALS INC's stock.
All SEC filings for CUMBERLAND PHARMACEUTICALS INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CPIX Stock Page
Frequently Asked Questions
Where can I read CPIX's SEC filings?
Browse all filings on our CPIX SEC filings page.
What types of SEC filings does CUMBERLAND PHARMACEUTICALS INC file?
Public companies like CUMBERLAND PHARMACEUTICALS INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
